WHAT IS CBC

CBC (cannabichromene) is a non-psychoactive minor cannabinoid found in cannabis at typical concentrations of 0.3–1%. It’s the third-most-abundant cannabinoid in many cultivars, after THC and CBD.

CBC interacts primarily with TRPV1 channels (the heat/pain receptors) and TRPA1 channels rather than CB1/CB2 receptors directly. This unique receptor profile is the basis for CBC’s anti-inflammatory and analgesic research interest.

Recent research has explored CBC’s role in neurogenesis (the formation of new brain cells) — preclinical models show CBC may stimulate neural progenitor cell development.

RESEARCH + USE

CBC is rarely sold as a standalone product. It’s most commonly present as a minor component in full-spectrum cannabis extracts where its contribution to the entourage effect is appreciated rather than isolated.

Some specialty wellness brands market CBC-enriched tinctures and topicals targeting inflammation. Research evidence is preclinical and limited.

Clinical research on CBC is early-stage. Most evidence is from animal studies and cell cultures.